Sharps Technology (NASDAQ:STSS – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “strong sell” rating to a “hold” rating in a report released on Thursday.
Sharps Technology Trading Up 2.8%
Shares of Sharps Technology stock opened at $4.05 on Thursday. The firm has a market capitalization of $218,700.00, a PE ratio of -0.50 and a beta of 2.14. The firm’s 50 day moving average is $14.16 and its 200 day moving average is $319.60. Sharps Technology has a 1 year low of $3.36 and a 1 year high of $5,446.32.
Sharps Technology (NASDAQ:STSS – Get Free Report) last announced its quarterly earnings results on Thursday, May 15th. The company reported $38.62 earnings per share (EPS) for the quarter.
Institutional Investors Weigh In On Sharps Technology
About Sharps Technology
Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.
Featured Stories
- Five stocks we like better than Sharps Technology
- What Are the FAANG Stocks and Are They Good Investments?
- Pfizer’s 7.5% Dividend: Income Haven or House of Cards?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Trades Members of Congress Are Making Right Now
- Using the MarketBeat Dividend Yield Calculator
- TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain
Receive News & Ratings for Sharps Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Technology and related companies with MarketBeat.com's FREE daily email newsletter.